The IPO for Medicamen Organics is a book-built issue amounting to Rs 10.54 crores. This offering consists solely of a fresh issue totaling 31 lakh shares.

The subscription period for the Medicamen Organics IPO starts on June 21, 2024, and ends on June 25, 2024. The share allotment is anticipated to be finalized on Wednesday, June 26, 2024, and the shares are expected to be listed on the NSE SME on Friday, June 28, 2024.

The IPO price range for Medicamen Organics is set between ₹32 and ₹34 per share. Investors must apply for a minimum of 4000 shares per lot, requiring at least ₹136,000 for a retail investment. High Net Worth Individuals (HNIs) must invest in a minimum of 2 lots, or 8,000 shares, which amounts to ₹272,000.

Medicamen Organics IPO Details

IPO DateJune 21, 2024 to June 25, 2024
Listing Date[.]
Face Value₹10 per shar
Price Band₹32 to ₹34 per share
Lot Size4000 Shares
Total Issue Size3,100,000 shares
(aggregating up to ₹10.54 Cr)
Fresh Issue3,100,000 shares
(aggregating up to ₹10.54 Cr)
Issue TypeBook Built Issue IPO
Listing AtNSE SME
Share holding pre issue8,600,000
Share holding post issue11,700,000
Market Maker portion172,000 shares

Medicamen Organics IPO Lot Size

Retail (Min)14000₹136,000
Retail (Max14000₹136,000
HNI (Min)28000₹272,000

Medicamen Organics IPO Objectives

The company intends to allocate the Net Proceeds from the Issue to the following purposes:

  1. Covering the costs associated with registering products in international markets.
  2. Updating the plant and enhancing production capacity.
  3. Meeting the company’s working capital needs.
  4. General corporate purposes

About Medicamen Organics Limited

Incorporated in 1995, Medicamen Organics Limited specializes in developing, manufacturing, and distributing pharmaceutical dosages, including generic forms such as tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders. The company serves both governmental bodies and private entities as a contract and third-party manufacturer.

Medicamen Organics Limited offers an extensive product range of 84 items, encompassing various drug categories such as antibacterial, antidiarrheal, antifungal, antimalarial, antidiabetic, proton pump inhibitors, antihistamines, antihypertensive drugs, lipid preparations, antiparasitics, multivitamin preparations, multimineral, and non-steroidal anti-inflammatory drug (NSAIDs).

Medicamen Organics Limited Financial Information

Period Ended31 Mar 202431 Mar 202331 Mar 202231 Mar 2021
Profit After Tax240.4195.789.2329.81
Net Worth1,518.40851.71755.92746.72
Reserves and Surplus658.40251.71155.92146.72
Total Borrowing1,265.651,179.501,024.57958.97

Medicamen Organics IPO Timeline

IPO Open DateFriday, June 21, 2024
IPO Close DateTuesday, June 25, 2024
Basis of AllotmentWednesday, June 26, 2024
Initiation of RefundsThursday, June 27, 2024
Credit of Shares to DematThursday, June 27, 2024
Listing DateFriday, June 28, 2024
Cut-off time for UPI mandate confirmation5 PM on June 25, 2024


Medicamen Organics Limited, established in 1995, is a prominent player in the pharmaceutical industry, specializing in the development, manufacture, and distribution of a wide array of generic pharmaceutical dosages. With a comprehensive product lineup and a robust distribution network across India and several international markets, the company serves both government and private sectors. The upcoming IPO aims to support the company’s growth initiatives, including product registration in international markets, plant upgrades, increased production capacity, working capital needs, and general corporate purposes

Write A Comment